Skip to main content
Top
Published in: European Journal of Medical Research 1/2021

Open Access 01-12-2021 | ANCA-Associated Vasculitis | Case report

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review

Authors: Rui Wu, Jiang Su, Yu-rong Zou, Jing Zhu

Published in: European Journal of Medical Research | Issue 1/2021

Login to get access

Abstract

Background

Systemic sclerosis (SSc) and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) both affect the kidney and may cause renal failure. Treatment of AAV is dramatically different from that of SSc renal crisis (SRC). Kidney biopsy is not recommended for diagnosing SRC, but it is the only reliable diagnostic method for AAV.

Case presentation

Here, a 49-year-old male patient with diffuse SSc presented with acute renal insufficiency and detectable ANCA with myeloperoxidase-specific antibodies. A renal biopsy revealed necrotizing glomerulonephritis and was consistent with AAV. This finding confirms the existence of AAV and SSc overlap syndrome. The patient was treated with intravenous methylprednisolone, intravenous cyclophosphamide, tandem membrane plasma exchange, and hemodialysis. After treatment, his clinical symptoms remained stable, and his creatinine and C-reactive protein (CRP) levels have remained normalized as of his most recent follow-up after hospital discharge.

Conclusions

AAV can overlap with SSc; although this condition is rare, it is associated with considerable morbidity and mortality. Therefore, it is critical to recognize AAV in the setting of worsening renal function due to SSs and provide appropriate treatment. Several clinical features are suggestive of AAV rather than SRC, but renal biopsy is required for accurate diagnosis.
Literature
1.
go back to reference Shanmugam VK, Steen VD. Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management. Curr Opin Rheumatol. 2012;24:669–76.CrossRef Shanmugam VK, Steen VD. Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management. Curr Opin Rheumatol. 2012;24:669–76.CrossRef
2.
go back to reference Galluccio F, Muller-Ladner U, Furst DE, et al. Points to consider in renal involvement in systemic sclerosis. Rheumatology (Oxford). 2017;56:v49–52.CrossRef Galluccio F, Muller-Ladner U, Furst DE, et al. Points to consider in renal involvement in systemic sclerosis. Rheumatology (Oxford). 2017;56:v49–52.CrossRef
3.
go back to reference Woodworth TG, Suliman YA, Li W, et al. Scleroderma renal crisis and renal involvement in systemic sclerosis. Nat Rev Nephrol. 2016;12:678–91.CrossRef Woodworth TG, Suliman YA, Li W, et al. Scleroderma renal crisis and renal involvement in systemic sclerosis. Nat Rev Nephrol. 2016;12:678–91.CrossRef
4.
go back to reference Nakazawa D, Masuda S, Tomaru U, et al. Pathogenesis and therapeutic interventions for anca-associated vasculitis. Nat Rev Rheumatol. 2019;15:91–101.CrossRef Nakazawa D, Masuda S, Tomaru U, et al. Pathogenesis and therapeutic interventions for anca-associated vasculitis. Nat Rev Rheumatol. 2019;15:91–101.CrossRef
5.
go back to reference Goceroglu A, Berden AE, Fiocco M, et al. Anca-associated glomerulonephritis: risk factors for renal relapse. PLoS ONE. 2016;11:e165402.CrossRef Goceroglu A, Berden AE, Fiocco M, et al. Anca-associated glomerulonephritis: risk factors for renal relapse. PLoS ONE. 2016;11:e165402.CrossRef
6.
go back to reference Berti A, Cornec D, Crowson CS, et al. The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in olmsted county, minnesota: a twenty-year us population-based study. Arthritis Rheumatol. 2017;69:2338–50.CrossRef Berti A, Cornec D, Crowson CS, et al. The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in olmsted county, minnesota: a twenty-year us population-based study. Arthritis Rheumatol. 2017;69:2338–50.CrossRef
7.
go back to reference Caramaschi P, Biasi D, Tonolli E, et al. Antineutrophil cytoplasmic antibodies in scleroderma patients: first report of a case with anti-proteinase 3 antibodies and review of the literature. Joint Bone Spine. 2002;69:177–80.CrossRef Caramaschi P, Biasi D, Tonolli E, et al. Antineutrophil cytoplasmic antibodies in scleroderma patients: first report of a case with anti-proteinase 3 antibodies and review of the literature. Joint Bone Spine. 2002;69:177–80.CrossRef
8.
go back to reference Rosato E, Gigante A, Barbano B, et al. Prognostic factors of renal involvement in systemic sclerosis. Kidney Blood Press Res. 2018;43:682–9.CrossRef Rosato E, Gigante A, Barbano B, et al. Prognostic factors of renal involvement in systemic sclerosis. Kidney Blood Press Res. 2018;43:682–9.CrossRef
9.
go back to reference Martin-Nares E, Zuniga-Tamayo D, Hinojosa-Azaola A. Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity. Clin Rheumatol. 2019;38:97–106.CrossRef Martin-Nares E, Zuniga-Tamayo D, Hinojosa-Azaola A. Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity. Clin Rheumatol. 2019;38:97–106.CrossRef
10.
go back to reference Guibert F, Garnier AS, Wacrenier S, et al. Patients with anca-associated glomerulonephritis and connective tissue diseases: a comparative study from the maine-anjou aav registry. J Clin Med. 2019;8:1218.CrossRef Guibert F, Garnier AS, Wacrenier S, et al. Patients with anca-associated glomerulonephritis and connective tissue diseases: a comparative study from the maine-anjou aav registry. J Clin Med. 2019;8:1218.CrossRef
11.
go back to reference Quemeneur T, Mouthon L, Cacoub P, et al. Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature. Medicine (Baltimore). 2013;92:1–9.CrossRef Quemeneur T, Mouthon L, Cacoub P, et al. Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature. Medicine (Baltimore). 2013;92:1–9.CrossRef
12.
go back to reference Moxey J, Huq M, Proudman S, et al. Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis. Arthritis Res Ther. 2019;21:57.CrossRef Moxey J, Huq M, Proudman S, et al. Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis. Arthritis Res Ther. 2019;21:57.CrossRef
13.
go back to reference Arad U, Balbir-Gurman A, Doenyas-Barak K, et al. Anti-neutrophil antibody associated vasculitis in systemic sclerosis. Semin Arthritis Rheum. 2011;41:223–9.CrossRef Arad U, Balbir-Gurman A, Doenyas-Barak K, et al. Anti-neutrophil antibody associated vasculitis in systemic sclerosis. Semin Arthritis Rheum. 2011;41:223–9.CrossRef
14.
go back to reference Kant S, Shah AA, Hummers LK, et al. Anca-associated vasculitis in scleroderma: a renal perspective. Clin Nephrol. 2018;90:413–8.CrossRef Kant S, Shah AA, Hummers LK, et al. Anca-associated vasculitis in scleroderma: a renal perspective. Clin Nephrol. 2018;90:413–8.CrossRef
15.
go back to reference Cheta J, Binder M, Kowalewska J, et al. Anca-associated vasculitis co-occurrence with systemic sclerosis: a case report of a rare diagnostic dilemma. J Investig Med High Impact Case Rep. 2018;6:1559716956. Cheta J, Binder M, Kowalewska J, et al. Anca-associated vasculitis co-occurrence with systemic sclerosis: a case report of a rare diagnostic dilemma. J Investig Med High Impact Case Rep. 2018;6:1559716956.
Metadata
Title
ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
Authors
Rui Wu
Jiang Su
Yu-rong Zou
Jing Zhu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2021
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-021-00500-2

Other articles of this Issue 1/2021

European Journal of Medical Research 1/2021 Go to the issue